The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An easy-to-use nomogram to predict overall survival (OS) at 6 months after initiation of FOLFIRINOX first-line chemotherapy in patients (pts) with metastatic pancreatic cancer (mPC).
 
Lorenzo Fornaro
No Relationships to Disclose
 
Francesco Leone
No Relationships to Disclose
 
Angelique Vienot
No Relationships to Disclose
 
Andrea Casadei Gardini
No Relationships to Disclose
 
Caterina Vivaldi
No Relationships to Disclose
 
Pasquale Lombardi
No Relationships to Disclose
 
Aurelia Meurisse
No Relationships to Disclose
 
Alessandro Passardi
No Relationships to Disclose
 
Enrico Vasile
No Relationships to Disclose
 
Emmanuele De Luca
No Relationships to Disclose
 
Julien Edeline
No Relationships to Disclose
 
Gianna Musettini
No Relationships to Disclose
 
Maria Antonietta Satolli
No Relationships to Disclose
 
Cindy Neuzillet
No Relationships to Disclose
 
Rosella Spadi
No Relationships to Disclose
 
Dewi Vernerey
No Relationships to Disclose
 
Alfredo Falcone
Honoraria - Lilly, Roche, Merck, Servier, Celgene
Consulting or Advisory Role - Amgen, Bayer, Bristol, Lilly, Merck, Roche, Sanofi, Servier
Research Funding - Amgen, Bayer, Merck, Roche, Sanofi, MSD, Servier (Inst)
 
Mario Clerico
No Relationships to Disclose
 
Astrid Lievre
No Relationships to Disclose
 
Francesco Montagnani
No Relationships to Disclose